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ABSTRACT: The role of inflammation in tendon injury is uncertain and a topic of current interest. In vitro studies of tendon
accelerated overload damage can serve as a valuable source of information on the early stages of tendinopathy. Viable fascicle bundles
from bovine flexor tendons were subjected to cyclic uniaxial loading from 1–10% strain. Immuno-staining for inflammatory markers
and matrix degradation markers was performed on the samples after mechanical testing. Loaded samples exhibited visible
extracellular matrix damage, with disrupted collagen fibers and fiber kinks, and notable damage to the interfascicular matrix.
Inflammatory markers COX-2 and IL-6 were only expressed in the cyclically loaded samples. Collagen degradation markers MMP-1
and C1,2C were colocalized in many areas, with staining occurring in the interfascicular matrix or the fascicular tenocytes. These
markers were present in control samples, but staining became increasingly intense with loading. Little MMP-3 or MMP-13 was evident
in control sections. In loaded samples, some sections showed intense staining of these markers, again localized to interfascicular
regions. This study suggests that inflammatory markers may be expressed rapidly after tendon overload exercise. Interestingly, both
inflammation and damage-induced matrix remodeling seem to be concentrated in, or in the vicinity of, the highly cellular
interfascicular matrix.  2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:889–897, 2015.
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Tendinopathy is a general term for chronic tendon
disease1 characterized by a combination of pain,
swelling, and impaired tendon performance.2 The
aetiology of this disease remains to be elucidated and
is likely to be multi-factorial. Tendinopathy is often
the result of damage accumulation during overuse,
and may also involve either mechanical over-stimula-
tion or under-stimulation of tenocytes and the related
(imbalanced) remodeling in tendon tissue.1 Tendinop-
athy has often been considered a degenerative disease1
not associated with inflammation. However the role of
inflammation within the initiation, progression, and
resolution of tendinopathy remains unclear.3
Tendons have an inhomogeneous multilevel hier-
archical composite structure. Considering the meso-
scale, looking at the largest hierarchical subunits in
tendon, it is possible to describe tendon as a compos-
ite material with two main phases (or matrix compo-
nents). The phases are the fascicles (fascicular
matrix, FM), which are longitudinal structures com-
posed predominantly of uniaxially arranged type I
collagen fibers, and the interfascicular matrix (IFM)
or endotenon that fills the spaces between fascicles
(see Fig. 1). IFM is a highly cellular matrix phase
consisting of a range of non-collagenous proteins
including elastin, proteoglycans, and also minor
collagens.4
The IFM has a more sparse fiber arrangement,
with lower volume fractions of fibrillar material than
fascicular matrix. Arrangement of fibers in the IFM is
more network-like, which suggests softer, and likely
more complex mechanical behavior5,6 as compared to
the uniaxially arranged, mainly collagen type I, fibers
in fascicles. The collagenous phase volume fraction
and the orientation of fibers both have previously
been shown to have a direct impact on tissue mechan-
ics,7–10 suggesting that the interfascicular matrix is
likely more prone to damage and injury. This softer
phase is thought to create sliding planes between
fascicles that facilitate increased tendon extension
and recoil.11 However, the exact role of the interfas-
cicular matrix in tendon injury or remodeling remains
uncertain.
Tendons are thought to undergo slow remodeling
mediated by matrix metalloproteinases (MMPs) and
disintegrins and metalloproteinases with thrombo-
spondin motifs (ADAMTS), whose activity is inhibited
though tissue inhibitors of metalloproteinases
(TIMPs).1
These enzymes, and their inhibitors, have roles in
extracellular matrix turnover in health but also in
pathological conditions. However, it remains unclear
how tendon turnover is mediated by the tendon cells.
The cell population in tendon is heterogeneous,
consisting of elongated tenocytes between collagen
fibers within the FM and IFM cells which are more
rounded in shape (Fig. 1). However, there are as yet
no specific markers to distinguish these types of cells
from each other or from other connective tissue
cells.1 It has been shown that cell shape is influenced
by local mechanical properties,12,13 and the two cell
populations of tendon likely live in mechanically
distinct environments (stiffer FM or softer IFM). In
addition, the IFM regions are more highly cellular
Grant sponsor: Wellcome Trust; Grant number: WT087112;
Grant sponsor: Arthritis Research UK; Grant number: 20262.
Correspondence to: Ewa M. Spiesz (T: þ44(0)20 7882 5194)
E-mail: e.spiesz@qmul.ac.uk
# 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
JOURNAL OF ORTHOPAEDIC RESEARCH JUNE 2015 889
than FM regions. The turnover of non-collagenous
matrix has been shown to be faster than that of
collagenous matrix in tendon. The greater quantity
of non-collagenous matrix in the IFM thus suggests
that IFM cells may be more active in healthy
turnover, but they may also play different roles in
tendon injury and repair.14
The role of an inflammatory response in tendinop-
athy has been discussed in the literature, but no
consensus has been achieved. How the inflammation
results in damage accumulation and the initiation of
tendinopathy is not easily investigated in human
subjects, because the affected tendons can normally
only be assessed scientifically once tendinopathic
changes are advanced. Therefore, in vitro studies of
the inflammatory response to induced tendon overload
damage can serve as a valuable source of information
on the early stages of tendinopathy. The goal of this
project was to investigate the influence of cyclic
overload exercise performed in vitro on the expression
of inflammatory mediators and markers of matrix
degradation in bovine tendons comparing the response
of FM and IFM regions. We hypothesized that cyclic
loading would result in an increase in the levels of the
inflammatory markers COX-2 and IL-6, and would
also increase levels of the matrix degrading enzymes
MMP-1, -3, and -13, resulting in increased collagen
degradation. Further we hypothesized that the re-
sponse to overload would be localized predominantly
in the IFM.
METHODS
Samples and Loading Protocol
Deep digital flexor tendons from the forelimbs of skeletally
mature adult cows aged 18 months (n¼ 3) were obtained
from an abattoir immediately post-mortem. As we aimed to
investigate the matrix response from both collagen-rich
fascicles and the interfascicular matrix, fascicle bundles
(n¼ 12) containing both types of matrix were dissected
(Fig. 2). The fascicle bundles we tested in this study were on
average 1.5mm in diameter, incorporating a minimum of
three fascicles. From each tendon, one fascicle bundle was
assigned to each test group:
1) CON - fresh control: snap frozen immediately after
dissection;
2) STA - static control: held at 1% strain for 24h;
3) 300C - cyclically loaded for 300 cycles (5min) from
1–10% uniaxial strain (1Hz) followed by 1% static
strain for 24h;
4) 1,800C - cyclically loaded for 1,800 cycles (30min)
from 1–10% uniaxial strain (1Hz) followed by 1%
static strain for 24h.
Samples from groups 2–4 were placed into individual
chambers of the multiple chamber system (Fig. 2), gripped
with a gauge length of 10mm. The cyclically loaded samples
(groups 3–4) were subjected to large cyclic strains from 1–
10%, using a Bose mechanical test system (Wintest v 4.0,
Bose Coorporation, USA) housed in an incubator. The strain-
ing regimes have previously been shown to simulate over-
Figure 1. Schematic and histological section of a bovine flexor tendon, depicting the two phases (components) of the tendons
structure at the meso-scale: collagen-rich fascicles, termed fascicular matrix (FM) and the surrounding endotendon, termed
interfascicular matrix (IFM). Notice the different cell shapes and numbers within fascicles (tenocytes) and the IFM (IFM cells). Cell
nuclei are stained with DAPI (blue).
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load.15 During testing the samples were maintained in sterile
cell culture medium (DMEM) supplemented with penicillin
(50U/ml), streptomycin (0.05mg/ml) and L-glutamine (2mM)
and maintained in an incubator at 37 ˚C, 20% O2, 5% CO2.
After the end of the 24h test period, samples were
removed from the chambers and snap frozen in optimal
cutting temperature (OCT compound, VWR) embedding
medium (cooled in hexane on dry ice) and stored at 80 ˚C.
Three 20mm thick longitudinal cryo-sections were cut from
each sample and mounted on poly-l-lysine coated slides for
further analysis.
Immuno-staining
Dual immuno-staining for the following three marker pairs
was performed:
 inflammatory markers - cyclooxygenase (COX-2)
and interleukin (IL-6).
 matrix degradation markers: matrix metalloprotei-
nase MMP-1 and collagen degradation marker
C1,2C.
 matrix degradation markers: matrix metalloprotei-
nases MMP-3 and MMP-13.
Details of the antibodies used are shown in Table 1.
Both the inflammatory markers selected, IL-624,25 and
COX-226,27 have previously been shown to be upregulated in
tendinopathy. MMPs 1 and 13 were selected as they are
known to be active against fibrillar collagens, including the
predominant collagen type I.1,28–30 MMP-3 was selected as it
degrades other minor proteins in tendon matrix, including
collagens III, IV, IX, and X, and also proteoglycans and
elastin.28–33 The C1,2C (or COL 2 3/4C short) antibody
detects the carboxy terminus of fragmented type I and II
collagen, cleaved by collagenases MMP-1, MMP-8 or MMP-
13.21,34–37
Cryo-sections were thawed and fixed with acetone and
then rehydrated in phosphate buffered saline (PBS, Sigma–
Aldrich) followed by tris buffered saline (TBS, Sigma–
Aldrich, Dorset, United Kingdom) plus 0.1% Triton X-100
(Sigma–Aldrich, Dorset, United Kingdom) to permeabilize
cell membranes. Blocking buffer-TBS with 1% bovine serum
albumin, (BSA, Sigma–Aldrich, Dorset, United Kingdom)
10% donkey serum (Sigma–Aldrich, Dorset, United Kingdom)
was applied to sections for 2h at room temperature. After
draining, the primaryantibodies diluted in blocking buffer
with 1% BSA were then applied. Concentrations of antibodies
used are listed in Table 1. For negative controls, blocking
buffer without the primary antibody was applied. Sections
were incubated overnight at 4 ˚C. Next, sections were rinsed
in TBS with 0.1% Triton, followed by the application of the
fluorophore-conjugated secondary antibodies, diluted to the
concentration listed in Table 1 in blocking buffer, and incubat-
ed for 1h at room temperature. This step was done in the
dark to avoid photo-bleaching. Finally, sections were rinsed in
PBS, mounted with DAPI containing mounting medium
(ProLong Gold, Life Technologies, Paisley, UK) and left
overnight at 4 ˚C to allow distinction of the highly cellular
IFM regions from less cellular fascicular regions. Negative
control sections were also imaged, to confirm lack of binding of
secondary antibodies.
Imaging, Image Processing, and Analysis
Sections were imaged with a confocal microscope (Leica TCS
SP2) using a 20 objective and 2digital zoom. Within each
slide, at least one region was imaged, in an area including
fascicular and interfascicular matrix. The region was select-
ed using bright field imaging, ensuring an area incorporating
both interfascicular matrix and fascicular matrix were select-
ed, but blinding the selector to the extent of staining for any
marker during region selection. Four matching images were
taken of each region: bright field; blue channel (wavelength
351nm) for visualization of DAPI showing cell nuclei; green
channel (wavelength 488nm); and red channel (wavelength
543nm) used for each pair of dual antibodies investigated.
Semi-quantitative analyses of the images were performed
in Gimp 2.8 software (GNU Image Manipulation Program).
Images were thresholded at a single level threshold (for a
given stain) and overlaid for visualization and to facilitate a
qualitative assessment of the extent and intensity of immuno-
staining within IFM and fascicles (FM). All images were
Figure 2. Loading system used to apply overload exercise to fascicle bundles.16 Test samples contain collagen-rich fascicles (gray) and
interfascicular matrix (yellow) which allows for later observation of the both regions’ response to overload exercise.
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assessed for the number of pixels falling above the threshold.
The brightness of each pixel falling above the threshold was
first measured after which an average image brightness was
calculated. Stain intensity was calculated, defined as the stain
brightness multiplied by the stained area.38
One hundred and eight stained sections have been imaged
and evaluated from which mean stain intensity and standard
deviation was determined for each antibody used across all
load conditions. Some images were discarded based on
features like prominent blood vessels in the field of view.
Sections with a bright background or large artefactual dots
visible across both green and red channels (possible dirt
particles) were also discarded.
RESULTS
Tendon Matrix Damage
Signs of fibrils damage were visible in sections of
tendons that were loaded for either 300 or 1,800 cycles
(marked with white ellipses in Figures 3, 4 and 5).
fiber kinks and damage were visible and increased in
severity with increasing load regime. Damage was also
evident in the IFM as disruption of the structure.
A semi-quantitative evaluation of the inflammatory
and matrix degradation markers was carried out, as
summarized in Figure 6 and discussed below.
Inflammatory Markers
Inflammatory markers were only expressed in the
cyclically loaded samples (see Fig. 3) with staining
seen within both the FM, and IFM.
The intensity of IL-6 staining was similar between
the samples loaded for 300 and 1,800 cycles, while the
areas of COX-2 staining (see Fig. 3) increased substan-
tially with increasing time of loading.
Matrix Degradation Markers
The matrix degrading enzyme MMP-1 and degrada-
tion marker C1,2C were present in control samples
(Fig. 4 a and d) as well as the loaded samples (Fig. 4 b,
c, e, f), with the high levels of these markers in
controls suggesting continuous tendon turnover.
MMP-1 and C1,2C were colocalized in many areas
therefore they are shown in separate images in
Figure 4. Whilst staining for these antibodies was
observed within the FM and often associated with
tenocytes, it was predominantly localized to the IFM,
suggesting that continual turnover is predominantly
localized to the IFM.
MMP-1 stain intensity (Fig. 6) showed a trend
towards increasing with loading, as did the area
stained with C1,2C. Standard deviations in MMP-1 and
C1,2C staining data were both high with different
tendons showing large variability. However data indi-
cated possible dose dependent staining, suggesting
increased collagen breakdown with more overload.
By contrast, little MMP-3 or MMP-13 was evident in
either control group. However, in loaded samples, some
sections showed increased staining of these markers,
again localized mainly to the IFM (see Fig. 5). While
MMP-3 staining showed a similar intensity in bothT
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loaded groups, the response appeared to be more strain
dose dependent for MMP-13 (Fig. 6).
Fold Change of Markers With Increasing Loading Time
Figure 7 presents the mean fold change in stain
intensity (stain brightness multiplied with stained
area) with respect to the fresh frozen controls (shown
by the horizontal dotted line) for each stain and all
load conditions. No visible changes were observed
between fresh frozen and static control samples for
any stain. Fold changes between fresh frozen and
static controls were between 1.1 and 1.6 for all stains
except MMP-3, where static controls showed, on aver-
age, less staining than the freshly frozen controls.
There are clear fold increases in inflammatory
markers with strain in loaded samples: 2.0 for IL-6
and 5.2 for COX-2, for the samples loaded for 1,800
cycles (Fig. 7). The highest fold increase of 17.7 was
observed for MMP-13.
Inflammatory markers and matrix degrading
enzymes MMP-3 and MMP-13 all showed a clear
increase with load, suggesting a response to cyclical
Figure 4. Typical static (a, d) and loaded (b, c, e, f) samples immunostained for collagen matrix degradation markers. MMP-1 and
C1,2C are colocalized and associated predominantly with the interfascicular matrix, in both control and loaded samples, indicating
continual turnover of the interfascicular matrix. Damaged areas of fibers, fiber kinks, and the IFM damage are marked with white
ellipses. Scale bar is 10mm.
Figure 3. Typical static (a) and loaded (b, c) samples immunostained for inflammatory markers. Damage is evident in both the
fascicles and the interfascicular matrix of the loaded samples (examples of damage— collagen fibers kinks and IFM disruption shown
with white ellipses). Both inflammatory markers were only expressed in loaded samples, with COX-2 expression increasing with the
cycle number. Scale bar is 10mm.
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mechanical loading. By contrast, MMP-1 and C1,2C
were both evident in control samples and showed little
change with loading, suggesting the constant turnover
is less affected by the range of the overload strains
applied in our in vitro experiments.
DISCUSSION
This study subjects viable bundles of fascicles from
bovine flexor tendons to overload damage, adopting
immunohistochemistry to investigate the cellular re-
sponse to injury. The in vitro overload protocol adopted
here has previously been validated, to ensure the
generation of accelerated matrix damage,15 and data
indicated a rapid inflammatory response from tendon
cells directly after overload. An in vitro model of overuse
such as this is unlikely to fully recapitulate the in vivo
environment, but allows for precise control of the loading
environment, which it is otherwise very difficult to
achieve. Further, our in vitro model is likely to result in
larger and more uniform straining across our fascicle
bundles than would be seen in vivo, where strains are
distributed across the whole tendon’s hierarchical struc-
ture and along the whole length of the tendon. However,
this accelerated fatigue model facilitates assessment of
the cell response to local tendon damage.16
Immuno-staining and semi-quantification relies on
sufficient antibodies having access to epitope binding
sites within the tissue section. The structure of the
two phases of tendon: FM and IFM is different, with
densely packed collagenous fibers (mainly collagen
type I) within the FM and sparser, network-like
fibrillar structure in the IFM. It is feasible that
antibody binding epitopes were more accessible in the
IFM than in the dense FM structure, which could
lead to diminished staining in the FM phase of
tendon. Also different antibodies are likely to have
different binding affinities, which makes the
comparison between different stains difficult. A de-
tailed solution for this problem could be devised
with molecular dynamics simulations of the particular
biological surface and the immuno-staining solution,
but this was not in the scope of the work presented
here.
This study suggests that inflammatory markers may
be expressed rapidly and early after tendon overload
exercise (within 24h following 5 or 30min of overload
exercise in our in vitro model), indicating that inflam-
mation may be an early occurrence in tendinopathy.
We choose to study IL-6 as this inflammatory mediator
has previously been linked to tendinopathy24 and COX-
2 as increased levels of COX-2 have been shown in
patellar tendinopathy,26,27 loaded human tendon cells39
and injured tendons.40 Other markers of inflammation
such as IL-1 were not included in this study but have
previously been implicated in tendinopathic ten-
dons41,42 or bursa of the shoulder.25 In contrast, other
studies have shown no inflammatory response related
to pathological tendons.43
Figure 5. Typical static (a, d) and loaded (b, c, e, f) samples immunostained for matrix degradation markers. MMP-13 is associated
with areas in which there is a large aggregation of tenocytes and in the interfascicular matrix. MMP-3 expression levels are higher and
also remain mainly related to interfascicular matrix. Damaged areas of fibers and the IFM are marked with white ellipses. Scale bar is
10mm.
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The levels of MMP-1 increased with loading, corre-
lating with previous studies, which have shown
increased MMP-1 expression in tendinopathic44,45 or
ruptured46 tendons. Further, MMP-1 expression has
recently been shown to increase with overload fatigue
inducing exercise in equine tendons.47 Interestingly,
the increased levels of MMP-1 in the IFM colocalized
with staining for the C1,2C marker that detects the
fragmented type I and II collagen, indicating that the
MMP-1 present is in an active form.
The up-regulation of MMP-3 and MMP-13 in the
current study also agrees with previous work, showing
up-regulation of both these MMPs in pathological
tendons.45,47–50 However, MMP-3 has also been shown
to be down-regulated in both ruptured and tendino-
pathic tendons, as shown by the mRNA expression
level.46 The difference in response may be attributed to
both timing (post-injury) and the method used for
identification of tissue response.
Interestingly, in this study, both inflammation and
damage-induced matrix remodeling seem to be concen-
trated in or in the vicinity of the IFM. This could be
partially explained by the high number of cells present
in the IFM as compared to fascicles, with more cells
available to respond to overload of the IFM. However,
it is also possible that IFM cells and tenocytes differ in
their phenotype and activity levels. Their respective
roles in initiation, progression, and resolution of
inflammation, and the consequences for tendinopathy
are yet to be elucidated.
Further, the mechanical role of IFM in tendon
extension remains unclear. However, it has been
hypothesized to be instrumental in allowing fas-
cicles to slide with respect to each other,11 allowing
higher tendon deformations before the onset of
fascicle damage. In physiological use, the IFM may
thus be subjected to higher shear stresses then the
fascicular matrix, and as a sparse, softer component
Figure 6. Changes in stain intensity for control samples (CON), statically loaded samples (STA), samples loaded for 300 cycles (300C)
and samples loaded for 1,800 cycles (1,800C) calculated as an average across the whole sample. Test groups show the mean values for
the stain intensity (defined as stain brightness multiplied by the stained area). Error bars show standard deviations and are shown for
all data sets. Note the differences in the levels of stain for different antibodies (y-axes), with the highest levels of expression for MMP-3
and the lowest for the inflammatory markers (IL-6 and COX-2).
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of tendon, may be more prone to damage and injury.
This could partially explain the higher turnover
rates in this phase as compared to fascicular matrix
(observed high levels of MMP-1 and C1,2C in control
samples). IFM may need to turnover more rapidly
and respond more robustly to damage to ensure
proper IFM and tendon function. Further character-
ization of the mechanobiology of the IFM is needed
to fully understand its role.
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